Expert Opinion on Biological Therapy, Volume 23, Issue 11 (2023)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Biological Therapy, Volume 23, Issue 11 (2023)

See all volumes and issues
Vol 24, 2024 Volume 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Antibody-drug conjugates

Editorial

Editorial
Antibody-drug conjugates in oncology: insights into Current challenges
Ahmad Z. Al Meslamani & Mohammad F. Bostanudin
Pages: 1035-1038
Published online: 15 Dec 2023
First Page PreviewforAntibody-drug conjugates in oncology: insights into Current challenges | Full Text | References | PDF (177.8 KB) | EPUB
  • 1107 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Antibody–drug conjugates targeting HER2-mutant or HER2-(non) amplified solid tumors: is HER2 an agnostic target?
Lorenzo Guidi, Carmine Valenza, Dario Trapani & Giuseppe Curigliano
Pages: 1039-1042
Published online: 15 Dec 2023
First Page PreviewforAntibody–drug conjugates targeting HER2-mutant or HER2-(non) amplified solid tumors: is HER2 an agnostic target? | Full Text | References | PDF (1.1 MB) | EPUB
  • 722 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Belantamab mafodotin in multiple myeloma
Enrica Antonia Martino, Antonella Bruzzese, Enrico Iaccino, Caterina Labanca, Francesco Mendicino, Selena Mimmi, Eugenio Lucia, Virginia Olivito, Antonino Neri, Fortunato Morabito, Ernesto Vigna & Massimo Gentile
Pages: 1043-1047
Published online: 27 May 2023
First Page PreviewforBelantamab mafodotin in multiple myeloma | Full Text | References | PDF (547.2 KB) | EPUB
  • 1101 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Editorial
What’s new in the use of antibody-drug conjugates (ADCs) delivering pyrrolobenzodiazepine (PBD) DNA cross-linkers for cancer therapy?
John A Hartley
Pages: 1049-1052
Published online: 15 Dec 2023
First Page PreviewforWhat’s new in the use of antibody-drug conjugates (ADCs) delivering pyrrolobenzodiazepine (PBD) DNA cross-linkers for cancer therapy? | Full Text | References | PDF (202.4 KB) | EPUB
  • 860 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Review

Review Article
Novel formats of antibody conjugates: recent advances in payload diversity, conjugation, and linker chemistry
Tomohiro Fujii & Yutaka Matsuda
Pages: 1053-1065
Published online: 15 Dec 2023
AbstractforNovel formats of antibody conjugates: recent advances in payload diversity, conjugation, and linker chemistry | Full Text | References | PDF (2.4 MB) | EPUB | Supplemental
  • 624 Views
  • 2 CrossRef citations
  • 0Altmetric
Review Article
The endosomal-lysosomal system in ADC design and cancer therapy
Jeffrey V. Leyton
Pages: 1067-1076
Published online: 15 Dec 2023
AbstractforThe endosomal-lysosomal system in ADC design and cancer therapy | Full Text | References | PDF (2.6 MB) | EPUB
  • 388 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Antibody-drug conjugates (ADCs) targeting TROP-2 in lung cancer
Lorenzo Belluomini, Alice Avancini, Marco Sposito, Michele Milella, Antonio Rossi & Sara Pilotto
Pages: 1077-1087
Published online: 03 Apr 2023
AbstractforAntibody-drug conjugates (ADCs) targeting TROP-2 in lung cancer | Full Text | References | PDF (1.1 MB) | EPUB
  • 5327 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Review Article
Antibody drug conjugates for glioblastoma: current progress towards clinical use
Hui K Gan, Sagun Parakh, Laura D Osellame, Lawrence Cher, Anthony Uccellini, Umbreen Hafeez, Siddharth Menon & Andrew M Scott
Pages: 1089-1102
Published online: 15 Dec 2023
AbstractforAntibody drug conjugates for glioblastoma: current progress towards clinical use | Full Text | References | PDF (5.2 MB) | EPUB
  • 260 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Managing adverse events of sacituzumab govitecan
Ilana Schlam, Paolo Tarantino & Sara M. Tolaney
Pages: 1103-1111
Published online: 15 Dec 2023
AbstractforManaging adverse events of sacituzumab govitecan | Full Text | References | PDF (1.1 MB) | EPUB
  • 877 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Non-traditional approaches for control of antibiotic resistance
Siddharth C Umarje & Sanjiban K Banerjee
Pages: 1113-1135
Published online: 15 Dec 2023
AbstractforNon-traditional approaches for control of antibiotic resistance | Full Text | References | PDF (1.6 MB) | EPUB
  • 118 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Discovery of novel cMET-targeting antibody Fab drug conjugates as potential treatment for solid tumors with highly expressed cMET
Reyna KV Lim, Matthew Buschman, Alisher Khasanov, Arthur Ledesma, Jiang Chen, Thanhtruc Nguyen, Xiao Guo, Lingna Li, Jonathan Huang, Jin Niu, Lisa Kerwin, Rengang Wang, Yurong Guo, Tong Zhu, Gunnar Kaufmann, Yanliang Zhang, Heyou Zhou, Henry Ji & Yanwen Fu
Pages: 1137-1149
Published online: 15 Dec 2023
AbstractforDiscovery of novel cMET-targeting antibody Fab drug conjugates as potential treatment for solid tumors with highly expressed cMET | Full Text | References | PDF (5.8 MB) | EPUB | Supplemental
  • 666 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Next-generation CD40 agonists for cancer immunotherapy
Hampus Andersson et al.
Review Article | Published online: 23 May 2024
Open Access
Non-TNF biologics and their biosimilars in rheumatoid arthritis
Tsz Ching Mok et al.
Review Article | Published online: 22 May 2024
Could siRNA therapeutics change the way we treat dyslipidemia?
Peter E. Penson et al.
Editorial | Published online: 22 May 2024
Free Access
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network
Andrea Spini et al.
Article | Published online: 21 May 2024
View all latest articles